Co-Delivery Nanosystems for Cancer Treatment: A Review
Reza Baradaran Eftekhari1, Niloufar Maghsoudnia1, Shabnam Samimi1
1Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Massive data available on cancer therapy more than ever lead our mind to the general concept that there is no perfect treatment for cancer. Indeed, the biological complexity of this disease is too excessive to be treated by a single therapeutic approach. Current delivery systems containing a specific drug or gene have their particular opportunities and restrictions. It is worth noting that a considerable number of studies suggest that single- drug delivery systems result in insufficient suppression of cancer growth. Therefore, one of the main ideas of co-delivery system designing is to enhance the intended response or to achieve the synergistic/combined effect compared to the single drug strategy. This review focuses on various strategies for co-delivery of therapeutic agents in the treatment of cancer. The primary approaches within the script are categorized into co-delivery of conventional chemotherapeutics, gene-based molecules, and plant-derived materials. Each one is explained in examples with the recent researches. In the end, a brief summary is provided to conclude the gist of the review.
Insights
Cancer treatment faces challenges due to disease complexity. Co-delivery systems combining multiple therapies, like chemotherapy, gene therapy, and plant-derived compounds, offer enhanced efficacy over single-agent approaches.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Cancer's biological complexity necessitates advanced therapeutic strategies.
- Single-drug delivery systems often show insufficient efficacy in suppressing tumor growth.
- Current delivery systems have inherent limitations, driving the need for innovative approaches.
Purpose of the Study:
- To review various strategies for co-delivery of therapeutic agents in cancer treatment.
- To explore the synergistic potential of combining different therapeutic modalities.
- To highlight recent advancements in co-delivery systems for oncology.
Main Methods:
- Categorization of co-delivery strategies into conventional chemotherapeutics, gene-based molecules, and plant-derived materials.
- Review of recent research examples for each category.
- Analysis of opportunities and restrictions of different co-delivery systems.
Main Results:
- Co-delivery systems can enhance therapeutic response and achieve synergistic effects.
- Combined approaches show improved cancer growth suppression compared to single-agent strategies.
- Diverse therapeutic agents, including chemotherapy, gene therapy, and natural compounds, are being co-delivered.
Conclusions:
- Co-delivery represents a promising strategy to overcome the limitations of single-agent cancer therapies.
- Synergistic combinations of therapeutic agents are crucial for improving treatment outcomes.
- Further research into advanced co-delivery systems is essential for effective cancer treatment.
Related Concept Videos
Treatment Resistant Cancers
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...


